Anti-CacyBP antibody [EPR12374]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal CacyBP antibody. Suitable for IHC-P, IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 5 publications.
View Alternative Names
S100A6BP, SIP, PNAS-107, CACYBP, Calcyclin-binding protein, CacyBP, hCacyBP, S100A6-binding protein, Siah-interacting protein
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CacyBP antibody [EPR12374] (AB171972)
Immunohistochemical analysis of paraffin-embedded Human gastric carcinoma tissue labeling CacyBP with ab171972 at 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CacyBP antibody [EPR12374] (AB171972)
Immunohistochemical analysis of paraffin-embedded Human gliocytoma tissue labeling CacyBP with ab171972 at 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CacyBP antibody [EPR12374] (AB171972)
Immunofluorescent analysis of MCF7 cells labeling CacyBP with ab171972 at 1/100 dilution. DAPI nuclear staining (blue).
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-CacyBP antibody [EPR12374] (AB171972)
Intracellular flow cytometric analysis of permeabilized 293T cells labeling CacyBPwith ab171972 at 1/10 dilution (red) orRabbit IgG (negative) (green).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CacyBP antibody [EPR12374] (AB171972)
Immunohistochemical analysis of paraffin-embedded Human Kidney tissue labeling CacyBP with ab171972 at 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-CacyBP antibody [EPR12374] (AB171972)
Western blot analysis on immunoprecipitation pellet from 293T cell lysate (lane 1) labeling CacyBP with ab171972 at 1/10 dilution or 1X PBS (lane 2) negative control. HRP-conjugated anti-Rabbit IgG preferentially detecting the non-reduced form of Rabbit IgG.
All lanes:
Immunoprecipitation - Anti-CacyBP antibody [EPR12374] (ab171972)
Predicted band size: 26 kDa
false
- WB
Supplier Data
Western blot - Anti-CacyBP antibody [EPR12374] (AB171972)
All lanes:
Western blot - Anti-CacyBP antibody [EPR12374] (ab171972) at 1/10000 dilution
Lane 1:
MCF7 cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
293T cell lysate at 10 µg
Lane 4:
PC3 cell lysate at 10 µg
Predicted band size: 26 kDa
false
- WB
Lab
Western blot - Anti-CacyBP antibody [EPR12374] (AB171972)
Western blot : Anti-CacyBP antibody [EPR12374] ab171972 staining at 1/10000 dilution, shown in green; Mouse anti alpha Tubulin ab7291 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 30 kDa in Wild-type A549 cell lysates with no signal observed at this size in CACYBP knockout A549 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-CacyBP antibody [EPR12374] (ab171972) at 1/10000 dilution
Lane 1:
Wild-type A549 at 20 µg
Lane 2:
CACYBP knockout A549 at 20 µg
Lane 3:
Raji at 20 µg
Lane 4:
PC-3 at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 26 kDa
Observed band size: 30 kDa,52 kDa
false
Related conjugates and formulations (1)
-
Anti-CacyBP antibody [EPR12374] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CacyBP regulates key cellular functions by interacting with signaling pathways and cytoskeletal elements. It can form part of multi-protein complexes influencing the stability and structure of cytoskeletal components. CacyBP also modifies proteins by dephosphorylation impacting processes such as cell division and differentiation. These functions underline its involvement in cellular maintenance and dynamic processes.
Pathways
CacyBP participates in cellular signaling and protein degradation pathways. It plays a role in the ubiquitin-proteasome pathway by mediating the degradation of specific substrate proteins. This protein associates with Siah-1 an E3 ubiquitin-protein ligase emphasizing its function in this pathway. CacyBP is also linked to ERK1/2 signaling pathways interacting with proteins like ERK2 to modulate cell proliferation and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Biomolecules & biomedicine 25:1801-1815 PubMed40167359
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncology research 31:317-331 PubMed37305391
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cancer research and clinical oncology 149:5761-5772 PubMed36576589
2022
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 58:102544 PubMed36427397
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 75:4371-4384 PubMed30032357
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com